{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:03:02Z","timestamp":1792508582245,"version":"4.5.0"},"reference-count":147,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009447","name":"Leukemia & Lymphoma Society of Canada","doi-asserted-by":"publisher","award":["513421"],"award-info":[{"award-number":["513421"]}],"id":[{"id":"10.13039\/100009447","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bprch.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.beha.2017.10.006","type":"journal-article","created":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T04:01:15Z","timestamp":1509508875000},"page":"2-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Pathogenesis of follicular lymphoma"],"prefix":"10.1016","volume":"31","author":[{"given":"Tracy","family":"Lackraj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6037-5582","authenticated-orcid":false,"given":"Rashmi","family":"Goswami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0287-7124","authenticated-orcid":false,"given":"Robert","family":"Kridel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beha.2017.10.006_bib1","doi-asserted-by":"crossref","first-page":"v83","DOI":"10.1093\/annonc\/mdw400","article-title":"Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"27","author":"Dreyling","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.beha.2017.10.006_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.beha.2017.10.006_bib3","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1172\/JCI63186","article-title":"Pathogenesis of follicular lymphoma","volume":"122","author":"Kridel","year":"2012","journal-title":"J\u00a0Clin Investig"},{"key":"10.1016\/j.beha.2017.10.006_bib4","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1182\/blood-2015-11-624288","article-title":"Follicular lymphoma: evolving therapeutic strategies","volume":"127","author":"Kahl","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.10.006_bib5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.beha.2011.02.007","article-title":"The microenvironment in follicular lymphoma","volume":"24","author":"de Jong","year":"2011","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.beha.2017.10.006_bib6","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.beha.2017.10.006_bib7","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1056\/NEJM198412063112303","article-title":"The natural history of initially untreated low-grade non-Hodgkin\u2019s lymphomas","volume":"311","author":"Horning","year":"1984","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beha.2017.10.006_bib8","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1182\/blood-2013-03-491514","article-title":"Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience","volume":"122","author":"Tan","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.10.006_bib9","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/leu.2014.251","article-title":"Follicular lymphoma in Sweden: nationwide improved survival in the rituximab era, particularly in elderly women - a Swedish Lymphoma Registry study","volume":"29","author":"Junlen","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2017.10.006_bib10","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1200\/JCO.1995.13.1.140","article-title":"Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single center","volume":"13","author":"Johnson","year":"1995","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.beha.2017.10.006_bib11","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1200\/JCO.2008.16.0283","article-title":"Population-based analysis of incidence and outcome of transformed non-Hodgkin\u2019s lymphoma","volume":"26","author":"Al-Tourah","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.beha.2017.10.006_bib12","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1182\/blood-2015-01-621375","article-title":"Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS)","volume":"126","author":"Wagner-Johnston","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.10.006_bib13","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1200\/JCO.2014.59.7534","article-title":"Early relapse of follicular lymphoma after rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone defines patients at high risk for death: an analysis from the national LymphoCare study","volume":"33","author":"Casulo","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.beha.2017.10.006_bib14","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1126\/science.6093263","article-title":"Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation","volume":"226","author":"Tsujimoto","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.beha.2017.10.006_bib15","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1126\/science.3874430","article-title":"Involvement of the bcl-2 gene in human follicular lymphoma","volume":"228","author":"Tsujimoto","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.beha.2017.10.006_bib16","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1126\/science.3929382","article-title":"The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining","volume":"229","author":"Tsujimoto","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.beha.2017.10.006_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-385991-4.00001-5","article-title":"Early steps of follicular lymphoma pathogenesis","volume":"111","author":"Roulland","year":"2011","journal-title":"Adv Immunol"},{"key":"10.1016\/j.beha.2017.10.006_bib18","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0092-8674(89)90174-8","article-title":"bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation","volume":"57","author":"McDonnell","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.beha.2017.10.006_bib19","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/349254a0","article-title":"Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18)","volume":"349","author":"McDonnell","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.beha.2017.10.006_bib20","first-page":"1","article-title":"Germinal center reentries of BCL2-overexpressing B cells drive follicular lymphoma progression","author":"Sungalee","year":"2014","journal-title":"J\u00a0Clin Investig"},{"key":"10.1016\/j.beha.2017.10.006_bib21","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1038\/emboj.2011.307","article-title":"Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases: deciphering cell death to improve cancer therapy","volume":"30","author":"Strasser","year":"2011","journal-title":"EMBO J"},{"key":"10.1016\/j.beha.2017.10.006_bib22","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1242\/jcs.031682","article-title":"Control of mitochondrial apoptosis by the Bcl-2 family","volume":"122","author":"Brunelle","year":"2009","journal-title":"J\u00a0Cell Sci"},{"key":"10.1016\/j.beha.2017.10.006_bib23","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.molcel.2011.10.001","article-title":"A\u00a0unified model of mammalian BCL-2 protein family interactions at the mitochondria","volume":"44","author":"Llambi","year":"2011","journal-title":"Mol Cell"},{"key":"10.1016\/j.beha.2017.10.006_bib24","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1182\/blood.V85.9.2528.bloodjournal8592528","article-title":"Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals","volume":"85","author":"Limpens","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.10.006_bib25","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1200\/JCO.1996.14.4.1333","article-title":"BCL-2\/JH rearrangements in circulating B cells of healthy blood donors and patients with nonmalignant diseases","volume":"14","author":"D\u00f6lken","year":"1996","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.beha.2017.10.006_bib26","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/ijc.23958","article-title":"Prevalence and frequency of circulating t(14;18)-MBR translocation carrying cells in healthy individuals","volume":"124","author":"Sch\u00fcler","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.beha.2017.10.006_bib27","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1084\/jem.20061292","article-title":"Follicular lymphoma-like B cells in healthy individuals: a novel intermediate step in early lymphomagenesis","volume":"203","author":"Roulland","year":"2006","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.beha.2017.10.006_bib28","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1365-2141.2007.06671.x","article-title":"Distribution of t(14;18)-positive, putative lymphoma precursor cells among B-cell subsets in healthy individuals1","volume":"138","author":"Hirt","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2017.10.006_bib29","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1182\/blood-2008-08-174839","article-title":"Transformation of follicular lymphoma to diffuse large B-cell lymphoma may occur by divergent evolution from a common progenitor cell or by direct evolution from the follicular lymphoma clone","volume":"113","author":"Carlotti","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.10.006_bib30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1158\/2159-8290.CD-11-0208","article-title":"Molecular ontogeny of donor-derived follicular lymphomas occurring after hematopoietic cell transplantation","volume":"2","author":"Weigert","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1016\/j.beha.2017.10.006_bib31","first-page":"1","article-title":"Risk of follicular lymphoma associated with BCL2 translocations in peripheral blood","author":"Hirt","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.beha.2017.10.006_bib32","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2013.52.8190","article-title":"t(14;18) translocation: a predictive blood biomarker for follicular lymphoma","volume":"32","author":"Roulland","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.beha.2017.10.006_bib33","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1182\/blood-2012-09-457283","article-title":"Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma","volume":"121","author":"Green","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.10.006_bib34","doi-asserted-by":"crossref","first-page":"E1116","DOI":"10.1073\/pnas.1501199112","article-title":"Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation","volume":"112","author":"Green","year":"2015","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.beha.2017.10.006_bib35","first-page":"1","article-title":"Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis","author":"Zhang","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.beha.2017.10.006_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/ncb3597","article-title":"Early loss of Crebbp confers malignant stem cell properties on lymphoid progenitors","author":"Horton","year":"2017","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.beha.2017.10.006_bib37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/gcc.20617","article-title":"Microarray-based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression status","volume":"48","author":"Schwaenen","year":"2009","journal-title":"Genes, Chromosom Cancer"},{"key":"10.1016\/j.beha.2017.10.006_bib38","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1002\/gcc.20606","article-title":"Prognostic significance of secondary cytogenetic alterations in follicular lymphomas","volume":"47","author":"Johnson","year":"2008","journal-title":"Genes, Chromosom Cancer"},{"key":"10.1016\/j.beha.2017.10.006_bib39","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1182\/blood-2008-02-140616","article-title":"Genome-wide profiling of follicular lymphoma by array comparative genomic hybridization reveals prognostically significant DNA copy number imbalances","volume":"113","author":"Cheung","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.10.006_bib40","doi-asserted-by":"crossref","first-page":"9166","DOI":"10.1158\/0008-5472.CAN-10-2460","article-title":"Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis","volume":"70","author":"Cheung","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.beha.2017.10.006_bib41","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.cell.2011.09.035","article-title":"The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma","volume":"147","author":"Oricchio","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.beha.2017.10.006_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002197","article-title":"Histological transformation and progression in follicular lymphoma: a clonal evolution study","volume":"13","author":"Kridel","year":"2016","journal-title":"PLOS Med"},{"key":"10.1016\/j.beha.2017.10.006_bib43","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cell.2013.03.008","article-title":"Interplay between the cancer genome and epigenome","volume":"153","author":"Shen","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.beha.2017.10.006_bib44","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nrg3554","article-title":"Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer","volume":"14","author":"Plass","year":"2013","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.beha.2017.10.006_bib45","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/cr.2011.22","article-title":"Regulation of chromatin by histone modifications","volume":"21","author":"Bannister","year":"2011","journal-title":"Cell Res"},{"key":"10.1016\/j.beha.2017.10.006_bib46","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ng.518","article-title":"Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin","volume":"42","author":"Morin","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.beha.2017.10.006_bib47","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10351","article-title":"Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma","volume":"476","author":"Morin","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.beha.2017.10.006_bib48","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nature09730","article-title":"Inactivating mutations of acetyltransferase genes in B-cell lymphoma","volume":"471","author":"Pasqualucci","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.beha.2017.10.006_bib49","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ng.2856","article-title":"Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma","volume":"46","author":"Okosun","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.beha.2017.10.006_bib50","first-page":"1","article-title":"The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development","author":"Ortega-Molina","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.beha.2017.10.006_bib51","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1182\/blood-2016-08-733469","article-title":"Crebbp loss cooperates with Bcl2 overexpression to promote lymphoma in mice","volume":"129","author":"Garc\u00eda-Ram\u00edrez","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.10.006_bib52","doi-asserted-by":"crossref","DOI":"10.1158\/2159-8290.CD-16-1417","article-title":"The crebbp acetyltransferase is a haploinsufficient tumor Suppressor in B Cell lymphoma","author":"Zhang","year":"2017","journal-title":"Cancer Discov"},{"key":"10.1016\/j.beha.2017.10.006_bib53","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ccr.2013.04.011","article-title":"EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation","volume":"23","author":"B\u00e9guelin","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.beha.2017.10.006_bib54","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/ng.3413","article-title":"DNA methylome analysis in Burkitt and follicular lymphomas identifies differentially methylated regions linked to somatic mutation and transcriptional control","volume":"47","author":"Kretzmer","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.beha.2017.10.006_bib55","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1182\/blood-2012-03-415380","article-title":"Identification of human germinal center light and dark zone cells and their relationship to human B-cell lymphomas","volume":"120","author":"Victora","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.10.006_bib56","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.immuni.2014.12.021","article-title":"Enhancer sequence variants and transcription-factor deregulation synergize to construct pathogenic regulatory circuits in B-Cell lymphoma","volume":"42","author":"Koues","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.beha.2017.10.006_bib57","first-page":"1","article-title":"Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry","volume":"2045","author":"Pastore","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.beha.2017.10.006_bib58","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1182\/blood-2016-07-729954","article-title":"Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma","volume":"129","author":"Krysiak","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.10.006_bib59","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1182\/blood-2014-06-582650","article-title":"Activating STAT6 mutations in follicular lymphoma","volume":"125","author":"Yildiz","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.10.006_bib60","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1600-065X.2012.01112.x","article-title":"Roles of BCL6 in normal and transformed germinal center B cells","volume":"247","author":"Basso","year":"2012","journal-title":"Immunol Rev"},{"key":"10.1016\/j.beha.2017.10.006_bib61","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1182\/blood-2002-08-2482","article-title":"BCL6 gene translocation in follicular lymphoma: a harbinger of eventual transformation to diffuse aggressive lymphoma","volume":"102","author":"Akasaka","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.10.006_bib62","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1182\/blood.V83.7.1757.1757","article-title":"Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin\u2019s lymphoma","volume":"83","author":"Lo Coco","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.10.006_bib63","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1182\/blood.V83.9.2423.2423","article-title":"LAZ3 rearrangements in non-Hodgkin\u2019s lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients","volume":"83","author":"Bastard","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.10.006_bib64","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1182\/blood.V85.10.2877.bloodjournal85102877","article-title":"Analysis of LAZ3 (BCL-6) status in B-cell non-Hodgkin\u2019s lymphomas: results of rearrangement and gene expression studies and a mutational analysis of coding region sequences","volume":"85","author":"Otsuki","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.10.006_bib65","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1182\/blood-2015-06-649905","article-title":"Cell of origin of transformed follicular lymphoma","volume":"126","author":"Kridel","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.10.006_bib66","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/ni.2688","article-title":"MEF2B mutations lead to deregulated expression of the oncogene BCL6 in diffuse large B cell lymphoma","volume":"14","author":"Ying","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.beha.2017.10.006_bib67","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1158\/2159-8290.CD-16-1189","article-title":"BCL6 antagonizes NOTCH2 to maintain survival of human follicular lymphoma cells","volume":"7","author":"Valls","year":"2017","journal-title":"Cancer Discov"},{"key":"10.1016\/j.beha.2017.10.006_bib68","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/ng.3473","article-title":"Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma","volume":"48","author":"Okosun","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.beha.2017.10.006_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.aak9969","article-title":"Genetic and epigenetic inactivation of <em>SESTRIN1<\/em> controls mTORC1 and response to EZH2 inhibition in follicular lymphoma","volume":"9","author":"Oricchio","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.beha.2017.10.006_bib70","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.cell.2016.08.032","article-title":"Loss of the HVEM tumor suppressor in lymphoma and restoration by modified CAR-t cells","volume":"167","author":"Boice","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.beha.2017.10.006_bib71","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/leu.2011.266","article-title":"High rate of TNFRSF14 gene alterations related to 1p36 region in de novo follicular lymphoma and impact on prognosis","volume":"26","author":"Launay","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2017.10.006_bib72","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1182\/blood-2009-06-225839","article-title":"Inactivating SOCS1 mutations are caused by aberrant somatic hypermutation and restricted to a subset of B-cell lymphoma entities","volume":"114","author":"Mottok","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.10.006_bib73","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1182\/blood-2004-09-3701","article-title":"Biallelic mutation SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line","volume":"105","author":"Melzner","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.10.006_bib74","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/j.humpath.2014.06.019","article-title":"Identification of MUM1 as a prognostic immunohistochemical marker in follicular lymphoma using computerized image analysis","volume":"45","author":"Xerri","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1016\/j.beha.2017.10.006_bib75","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1182\/blood.V85.12.3671.bloodjournal85123671","article-title":"Prognostic value of cellular proliferation and histologic grade in follicular lymphoma","volume":"85","author":"Martin","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.10.006_bib76","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/ijc.20354","article-title":"Cyclin D3 immunoreactivity in follicular lymphoma is independent of the t(6;14)(p21.1;q32.3) translocation or cyclin D3 gene amplification and is correlated with histologic grade and Ki-67 labeling index","volume":"112","author":"Pruneri","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.beha.2017.10.006_bib77","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1084\/jem.20132120","article-title":"Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapy","volume":"211","author":"Oricchio","year":"2014","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.beha.2017.10.006_bib78","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1038\/sj.leu.2400822","article-title":"In\u00a0vitro activation of low-grade non-Hodgkin\u2019s lymphoma by murine fibroblasts, IL-4, anti-CD40 antibodies and the soluble CD40 ligand","volume":"11","author":"Buske","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2017.10.006_bib79","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V82.6.1848.1848","article-title":"Isolated follicular lymphoma cells are resistant to apoptosis and can be grown in\u00a0vitro in the CD40\/stromal cell system","volume":"82","author":"Johnson","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.10.006_bib80","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.4049\/jimmunol.144.7.2550","article-title":"Induction of proliferation of human follicular (B type) lymphoma cells by cognate interaction with CD4+ T cell clones","volume":"144","author":"Umetsu","year":"1990","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.beha.2017.10.006_bib81","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa041869","article-title":"Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells","volume":"351","author":"Dave","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beha.2017.10.006_bib82","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2141.2006.06255.x","article-title":"Differential gene expression in non-malignant tumour microenvironment is associated with outcome in follicular lymphoma patients treated with rituximab and CHOP","volume":"135","author":"Harjunp\u00e4\u00e4","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2017.10.006_bib83","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrc3774","article-title":"The tumour microenvironment in B cell lymphomas","volume":"14","author":"Scott","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.beha.2017.10.006_bib84","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1200\/JCO.2012.44.2137","article-title":"Follicular lymphoma cells induce changes in T-cell gene expression and function: potential impact on survival and risk of transformation","volume":"31","author":"Kiaii","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.beha.2017.10.006_bib85","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1038\/leu.2010.223","article-title":"Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent T(FH)-B cell axis","volume":"24","author":"Pangault","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2017.10.006_bib86","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/leu.2011.301","article-title":"Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cells","volume":"26","author":"Am\u00e9-Thomas","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2017.10.006_bib87","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1182\/blood-2011-08-370908","article-title":"Mesenchymal stromal cells orchestrate follicular lymphoma cell niche through the CCL2-dependent recruitment and polarization of monocytes","volume":"119","author":"Guilloton","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.10.006_bib88","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1182\/blood-2016-08-737239","article-title":"IL-4\/CXCL12 loop is a key regulator of lymphoid stroma function in follicular lymphoma","volume":"129","author":"Pandey","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.10.006_bib89","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1182\/blood-2009-04-217687","article-title":"Follicular lymphoma cells induce T-cell immunologic synapse dysfunction that can be repaired with lenalidomide: implications for the tumor microenvironment and immunotherapy","volume":"114","author":"Ramsay","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.10.006_bib90","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.celrep.2013.12.027","article-title":"Genetics of follicular lymphoma transformation","volume":"6","author":"Pasqualucci","year":"2014","journal-title":"Cell Rep"},{"key":"10.1016\/j.beha.2017.10.006_bib91","doi-asserted-by":"crossref","first-page":"6770","DOI":"10.1073\/pnas.89.15.6770","article-title":"Clonal evolution of a follicular lymphoma: evidence for antigen selection","volume":"89","author":"Bahler","year":"1992","journal-title":"Proc Natl Acad Sci U. S. A"},{"key":"10.1016\/j.beha.2017.10.006_bib92","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.4049\/jimmunol.1300179","article-title":"Nonstereotyped lymphoma B cell receptors recognize vimentin as a shared autoantigen","volume":"190","author":"Cha","year":"2013","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.beha.2017.10.006_bib93","doi-asserted-by":"crossref","first-page":"4182","DOI":"10.1182\/blood-2012-05-427534","article-title":"Self-antigen recognition by follicular lymphoma B-cell receptors","volume":"120","author":"Sachen","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.10.006_bib94","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1182\/blood.V99.7.2562","article-title":"Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma","volume":"99","author":"Zhu","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.10.006_bib95","doi-asserted-by":"crossref","first-page":"7405","DOI":"10.1074\/jbc.M602690200","article-title":"Human follicular lymphoma cells contain oligomannose glycans in the antigen-binding site of the B-cell receptor","volume":"282","author":"Radcliffe","year":"2007","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.beha.2017.10.006_bib96","doi-asserted-by":"crossref","first-page":"18587","DOI":"10.1073\/pnas.1009388107","article-title":"Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectins","volume":"107","author":"Coelho","year":"2010","journal-title":"Proc Natl Acad Sci U. S. A"},{"key":"10.1016\/j.beha.2017.10.006_bib97","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1182\/blood-2015-04-640805","article-title":"Lectin binding to surface Ig variable regions provides a universal persistent activating signal for follicular lymphoma cells","volume":"126","author":"Linley","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.10.006_bib98","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1158\/1078-0432.CCR-14-3253","article-title":"The prognostic impact of CD163-positive macrophages in follicular lymphoma: a study from the BC cancer agency and the lymphoma study association","volume":"21","author":"Kridel","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.beha.2017.10.006_bib99","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.10.006_bib100","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1182\/blood.V99.9.3376","article-title":"In situ localization of follicular lymphoma: description and analysis by laser capture microdissection","volume":"99","author":"Cong","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.10.006_bib101","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1182\/blood-2011-05-355255","article-title":"Follicular lymphoma in situ: clinical implications and comparisons with partial involvement by follicular lymphoma","volume":"118","author":"Jegalian","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.10.006_bib102","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1182\/blood-2011-05-355255","article-title":"Follicular lymphoma in situ: clinical implications and comparisons with partial involvement by follicular lymphoma","volume":"118","author":"Jegalian","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.10.006_bib103","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/jclinpath-2015-202933","article-title":"A\u00a0retrospective study of patients with follicular lymphoma (FL): identification of in situ FL or FL-like B cells of uncertain significance in lymph nodes resected at the time of previous surgery for carcinomas","volume":"68","author":"Morita","year":"2015","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.beha.2017.10.006_bib104","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/leu.2013.307","article-title":"Increasing genomic and epigenomic complexity in the clonal evolution from in situ to manifest t(14;18)-positive follicular lymphoma","volume":"28","author":"Schmidt","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2017.10.006_bib105","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3324\/haematol.2013.094474","article-title":"Early lesions of follicular lymphoma: a genetic perspective","volume":"99","author":"Mamessier","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2017.10.006_bib106","series-title":"WHO classification of tumours of haematopoeitic and lymphoid tissues","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.beha.2017.10.006_bib107","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1182\/blood-2006-09-045989","article-title":"CD10-MUM1+ follicular lymphoma lacks BCL2 gene translocation and shows characteristic biologic and clinical features","volume":"109","author":"Karube","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.10.006_bib108","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/modpathol.2008.75","article-title":"BCL6 gene amplification\/3q27 gain is associated with unique clinicopathological characteristics among follicular lymphoma without BCL2 gene translocation","volume":"21","author":"Karube","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.beha.2017.10.006_bib109","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1046\/j.1365-2141.2003.04086.x","article-title":"Follicular lymphoma lacking the t(14;18)(q32;q21): identification of two disease subtypes","volume":"120","author":"Horsman","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2017.10.006_bib110","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/modpathol.2009.81","article-title":"t(14;18)-negative follicular lymphomas are associated with a high frequency of BCL6 rearrangement at the alternative breakpoint region","volume":"22","author":"Gu","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.beha.2017.10.006_bib111","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1182\/blood-2009-01-198580","article-title":"Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations","volume":"114","author":"Leich","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.10.006_bib112","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1182\/blood-2012-05-429514","article-title":"Pediatric-type nodal follicular lymphoma: an indolent clonal proliferation in children and adults with high proliferation index and no BCL2 rearrangement","volume":"120","author":"Louissaint","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.10.006_bib113","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/PAS.0b013e31826b9b57","article-title":"Follicular lymphomas in children and young adults: a comparison of the pediatric variant with usual follicular lymphoma","volume":"37","author":"Liu","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.beha.2017.10.006_bib114","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3324\/haematol.2012.073916","article-title":"Recurrent loss of heterozygosity in 1p36 associated with TNFRSF14 mutations in IRF4 translocation negative pediatric follicular lymphomas","volume":"98","author":"Martin-Guerrero","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2017.10.006_bib115","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1182\/blood-2016-03-703819","article-title":"Genome-wide analysis of pediatric-type follicular lymphoma reveals low genetic complexity and recurrent alterations of TNFRSF14 gene","volume":"128","author":"Schmidt","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.10.006_bib116","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/modpathol.2016.102","article-title":"A\u00a0study of the mutational landscape of pediatric-type follicular lymphoma and pediatric nodal marginal zone lymphoma","volume":"29","author":"Ozawa","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.beha.2017.10.006_bib117","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1182\/blood-2015-12-682591","article-title":"Pediatric-type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathway mutations","volume":"128","author":"Louissaint","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.10.006_bib118","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1200\/JCO.2010.32.9193","article-title":"Primary follicular lymphoma of the duodenum is a distinct mucosal\/submucosal variant of follicular lymphoma: a retrospective study of 63 cases","volume":"29","author":"Schmatz","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.beha.2017.10.006_bib119","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/modpathol.2012.127","article-title":"Duodenal follicular lymphoma lacks AID but expresses BACH2 and has memory B-cell characteristics","volume":"26","author":"Takata","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.beha.2017.10.006_bib120","first-page":"1","article-title":"Duodenal follicular lymphoma: comprehensive gene expression analysis with insights into pathogenesis","author":"Takata","year":"2014","journal-title":"Cancer Sci"},{"key":"10.1016\/j.beha.2017.10.006_bib121","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/gcc.10314","article-title":"Identification of cytogenetic subgroups and karyotypic pathways of clonal evolution in follicular lymphomas","volume":"39","author":"H\u00f6glund","year":"2004","journal-title":"Genes Chromosom Cancer"},{"key":"10.1016\/j.beha.2017.10.006_bib122","doi-asserted-by":"crossref","first-page":"7180","DOI":"10.1158\/1078-0432.CCR-08-0752","article-title":"Clonal evolution in t(14;18)-positive follicular lymphoma, evidence for multiple common pathways, and frequent parallel clonal evolution","volume":"14","author":"d'Amore","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.beha.2017.10.006_bib123","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1182\/blood.V91.11.4292","article-title":"Analysis of VH genes in follicular and diffuse lymphoma shows ongoing somatic mutation and multiple isotype transcripts in early disease with changes during disease progression","volume":"91","author":"Ottensmeier","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.10.006_bib124","first-page":"456","article-title":"Genomic and epigenomic co-evolution in follicular lymphomas","author":"Loeffler","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2017.10.006_bib125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134833","article-title":"High throughput sequencing analysis of the immunoglobulin heavy chain gene from flow-sorted B cell sub-populations define the dynamics of follicular lymphoma clonal evolution","volume":"10","author":"Carlotti","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.beha.2017.10.006_bib126","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aai8545","article-title":"Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA","volume":"8","author":"Scherer","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.beha.2017.10.006_bib127","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3324\/haematol.2012.074252","article-title":"Somatic hypermutation analysis in follicular lymphoma provides evidence suggesting bidirectional cell migration between lymph node and bone marrow during disease progression and relapse","volume":"98","author":"Wartenberg","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2017.10.006_bib128","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1200\/JCO.2006.09.3260","article-title":"Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-Cell lymphoma","volume":"25","author":"Montoto","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.beha.2017.10.006_bib129","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1200\/JCO.1997.15.4.1587","article-title":"Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients","volume":"15","author":"Bastion","year":"1997","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.beha.2017.10.006_bib130","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1182\/blood-2017-03-691345","article-title":"Can histologic transformation of follicular lymphoma be predicted and prevented?","volume":"130","author":"Kridel","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.10.006_bib131","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1200\/JCO.2012.48.3990","article-title":"Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the university of Iowa\/Mayo clinic specialized program of research excellence molecular epidemiology resource","volume":"31","author":"Link","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.beha.2017.10.006_bib132","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1200\/JCO.2015.65.7163","article-title":"Risk factors and outcomes for patients with follicular lymphoma who had histologic transformation after response to first-line immunochemotherapy in the PRIMA trial","volume":"34","author":"Sarkozy","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.beha.2017.10.006_bib133","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.beha.2011.02.006","article-title":"Transformation of follicular lymphoma","volume":"24","author":"Lossos","year":"2011","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.beha.2017.10.006_bib134","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1182\/blood-2009-03-212191","article-title":"Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival","volume":"114","author":"Johnson","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.10.006_bib135","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1182\/blood.V82.8.2289.2289","article-title":"p53 mutations are associated with histologic transformation of follicular lymphoma","volume":"82","author":"Lo Coco","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.10.006_bib136","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1182\/blood.V82.7.1994.1994","article-title":"p53 mutation is associated with progression in follicular lymphomas","volume":"82","author":"Sander","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.10.006_bib137","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1182\/blood.V80.3.758.758","article-title":"MYC rearrangements in histologically progressed follicular lymphomas","volume":"80","author":"Yano","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.10.006_bib138","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1038\/sj.leu.2404696","article-title":"Genome-wide detection of recurring sites of uniparental disomy in follicular and transformed follicular lymphoma","volume":"21","author":"Fitzgibbon","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2017.10.006_bib139","doi-asserted-by":"crossref","first-page":"8886","DOI":"10.1073\/pnas.132253599","article-title":"Transformation of follicular lymphoma to diffuse large-cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes","volume":"99","author":"Lossos","year":"2002","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.beha.2017.10.006_bib140","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1182\/blood-2013-05-500595","article-title":"Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma","volume":"123","author":"Bouska","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.10.006_bib141","first-page":"1","volume":"vol. 8","author":"Bouska","year":"2016"},{"key":"10.1016\/j.beha.2017.10.006_bib142","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","article-title":"Stromal gene signatures in large-B-cell lymphomas","volume":"359","author":"Lenz","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beha.2017.10.006_bib143","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1200\/JCO.2014.55.5714","article-title":"Lenalidomide combined with R-CHOP overcomes negative prognostic impact of non-germinal center B-cell phenotype in newly diagnosed diffuse large B-cell lymphoma: a phase II study","volume":"33","author":"Nowakowski","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.beha.2017.10.006_bib144","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nm.3884","article-title":"Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma","volume":"21","author":"Wilson","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.beha.2017.10.006_bib145","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1365-2141.2006.06439.x","article-title":"Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms","volume":"136","author":"Davies","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2017.10.006_bib146","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.3109\/10428194.2014.885513","article-title":"Chemoimmunotherapy resistant follicular lymphoma: predictors of resistance, association with transformation and prognosis","volume":"55","author":"Mozessohn","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.beha.2017.10.006_bib147","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/ajh.24492","article-title":"Early event status informs subsequent outcome in newly diagnosed follicular lymphoma","volume":"91","author":"Maurer","year":"2016","journal-title":"Am J Hematol"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692617300579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692617300579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T16:55:10Z","timestamp":1693155310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692617300579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":147,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S1521692617300579"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2017.10.006","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732706284.793557433","asserted-by":"object"}]},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathogenesis of follicular lymphoma","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Haematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beha.2017.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}